Sam-A Pharm삼아제약
009300 · KOSDAQ · ₩009300 · 삼아제약
₩13,630▼ ₩20 (0.15%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 14, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Apr 22, 2026Open on DART
- Amended: Annual general meeting results[기재정정]정기주주총회결과Mar 30, 2026Open on DART
- Corporate value-up plan기업가치제고계획(자율공시)Mar 27, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 20, 2026Open on DART
- Audit report submitted감사보고서제출Mar 19, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 26, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Feb 26, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 26, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 26, 2026Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 13, 2025Open on DART
- Amended: Insider shareholding report[기재정정]임원ㆍ주요주주특정증권등소유상황보고서Aug 25, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 25, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Amended: Quarterly report (Mar 2025)[기재정정]분기보고서 (2025.03)May 15, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 13, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 28, 2025Open on DART
- Audit report submitted감사보고서제출Mar 20, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 20, 2025Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 17, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 13, 2025Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Feb 28, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Feb 28, 2025Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 26, 2025Open on DART
- Amended: Quarterly report (Sep 2024)[기재정정]분기보고서 (2024.09)Dec 10, 2024Open on DART
- Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 14, 2024Open on DART
- Half-year report (Jun 2024)반기보고서 (2024.06)Aug 14, 2024Open on DART
- Quarterly report (Mar 2024)분기보고서 (2024.03)May 13, 2024Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2024Open on DART
- Audit report submitted감사보고서제출Mar 20, 2024Open on DART
- Annual report (Dec 2023)사업보고서 (2023.12)Mar 20, 2024Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 15, 2024Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 13, 2024Open on DART
- Shareholders' meeting called주주총회소집결의Mar 11, 2024Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 28, 2024Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 28, 2024Open on DART
- Quarterly report (Sep 2023)분기보고서 (2023.09)Nov 14, 2023Open on DART
- Half-year report (Jun 2023)반기보고서 (2023.06)Aug 14, 2023Open on DART
- Quarterly report (Mar 2023)분기보고서 (2023.03)May 15, 2023Open on DART
- Annual general meeting results정기주주총회결과Mar 30, 2023Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 23, 2023Open on DART
- Audit report submitted감사보고서제출Mar 22, 2023Open on DART
- Annual report (Dec 2022)사업보고서 (2022.12)Mar 22, 2023Open on DART
- [첨부정정]의결권대리행사권유참고서류Mar 15, 2023Open on DART
- 의결권대리행사권유참고서류Mar 15, 2023Open on DART
Titles in Korean until English translations are added.
Also known as: Sam-A Pharm / 삼아제약 / 009300 / KRX:009300
Source: KRX statistical information